182 related articles for article (PubMed ID: 30942216)
1. Cytosolic delivery of CRISPR/Cas9 ribonucleoproteins for genome editing using chitosan-coated red fluorescent protein.
Qiao J; Sun W; Lin S; Jin R; Ma L; Liu Y
Chem Commun (Camb); 2019 Apr; 55(32):4707-4710. PubMed ID: 30942216
[TBL] [Abstract][Full Text] [Related]
2. Direct Cytosolic Delivery of CRISPR/Cas9-Ribonucleoprotein for Efficient Gene Editing.
Mout R; Ray M; Yesilbag Tonga G; Lee YW; Tay T; Sasaki K; Rotello VM
ACS Nano; 2017 Mar; 11(3):2452-2458. PubMed ID: 28129503
[TBL] [Abstract][Full Text] [Related]
3. Dynamics and competition of CRISPR-Cas9 ribonucleoproteins and AAV donor-mediated NHEJ, MMEJ and HDR editing.
Fu YW; Dai XY; Wang WT; Yang ZX; Zhao JJ; Zhang JP; Wen W; Zhang F; Oberg KC; Zhang L; Cheng T; Zhang XB
Nucleic Acids Res; 2021 Jan; 49(2):969-985. PubMed ID: 33398341
[TBL] [Abstract][Full Text] [Related]
4. Biomimetic Mineralization-Based CRISPR/Cas9 Ribonucleoprotein Nanoparticles for Gene Editing.
Li S; Song Z; Liu C; Chen XL; Han H
ACS Appl Mater Interfaces; 2019 Dec; 11(51):47762-47770. PubMed ID: 31773942
[TBL] [Abstract][Full Text] [Related]
5. CRISPR/Cas9; A robust technology for producing genetically engineered plants.
Farooq R; Hussain K; Nazir S; Javed MR; Masood N
Cell Mol Biol (Noisy-le-grand); 2018 Nov; 64(14):31-38. PubMed ID: 30511631
[TBL] [Abstract][Full Text] [Related]
6. CRISPR/Cas9 ribonucleoprotein-mediated genome and epigenome editing in mammalian cells.
Bloomer H; Khirallah J; Li Y; Xu Q
Adv Drug Deliv Rev; 2022 Feb; 181():114087. PubMed ID: 34942274
[TBL] [Abstract][Full Text] [Related]
7. Speed genome editing by transient CRISPR/Cas9 targeting and large DNA fragment deletion.
Luo J; Lu L; Gu Y; Huang R; Gui L; Li S; Qi X; Zheng W; Chao T; Zheng Q; Liang Y; Zhang L
J Biotechnol; 2018 Sep; 281():11-20. PubMed ID: 29886029
[TBL] [Abstract][Full Text] [Related]
8. The application of CRISPR-Cas9 genome editing in Caenorhabditis elegans.
Xu S
J Genet Genomics; 2015 Aug; 42(8):413-21. PubMed ID: 26336798
[TBL] [Abstract][Full Text] [Related]
9. CRISPR/Cas9-mediated correction of human genetic disease.
Men K; Duan X; He Z; Yang Y; Yao S; Wei Y
Sci China Life Sci; 2017 May; 60(5):447-457. PubMed ID: 28534256
[TBL] [Abstract][Full Text] [Related]
10. Exploring the potential of genome editing CRISPR-Cas9 technology.
Singh V; Braddick D; Dhar PK
Gene; 2017 Jan; 599():1-18. PubMed ID: 27836667
[TBL] [Abstract][Full Text] [Related]
11. Gene Editing in Green Alga Chlamydomonas reinhardtii via CRISPR-Cas9 Ribonucleoproteins.
Kelterborn S; Boehning F; Sizova I; Baidukova O; Evers H; Hegemann P
Methods Mol Biol; 2022; 2379():45-65. PubMed ID: 35188655
[TBL] [Abstract][Full Text] [Related]
12. Increasing the efficiency of CRISPR-Cas9-VQR precise genome editing in rice.
Hu X; Meng X; Liu Q; Li J; Wang K
Plant Biotechnol J; 2018 Jan; 16(1):292-297. PubMed ID: 28605576
[TBL] [Abstract][Full Text] [Related]
13. Conversion Tract Analysis of Homology-Directed Genome Editing Using Oligonucleotide Donors.
Kan Y; Hendrickson EA
Methods Mol Biol; 2019; 1999():131-144. PubMed ID: 31127573
[TBL] [Abstract][Full Text] [Related]
14. Efficient Intracellular Delivery of CRISPR-Cas Ribonucleoproteins through Receptor Mediated Endocytosis.
Rouet R; Christ D
ACS Chem Biol; 2019 Mar; 14(3):554-561. PubMed ID: 30779874
[TBL] [Abstract][Full Text] [Related]
15. Genome editing in the mouse brain with minimally immunogenic Cas9 RNPs.
Stahl EC; Sabo JK; Kang MH; Allen R; Applegate E; Kim SE; Kwon Y; Seth A; Lemus N; Salinas-Rios V; Soczek KM; Trinidad M; Vo LT; Jeans C; Wozniak A; Morris T; Kimberlin A; Foti T; Savage DF; Doudna JA
Mol Ther; 2023 Aug; 31(8):2422-2438. PubMed ID: 37403358
[TBL] [Abstract][Full Text] [Related]
16. Lentiviral Capsid-Mediated
Lu Z; Yao X; Lyu P; Yadav M; Yoo K; Atala A; Lu B
CRISPR J; 2021 Dec; 4(6):914-928. PubMed ID: 33733873
[TBL] [Abstract][Full Text] [Related]
17. CRISPR-Cas9-mediated genome editing in apple and grapevine.
Osakabe Y; Liang Z; Ren C; Nishitani C; Osakabe K; Wada M; Komori S; Malnoy M; Velasco R; Poli M; Jung MH; Koo OJ; Viola R; Nagamangala Kanchiswamy C
Nat Protoc; 2018 Dec; 13(12):2844-2863. PubMed ID: 30390050
[TBL] [Abstract][Full Text] [Related]
18. Genome editing in potato via CRISPR-Cas9 ribonucleoprotein delivery.
Andersson M; Turesson H; Olsson N; Fält AS; Ohlsson P; Gonzalez MN; Samuelsson M; Hofvander P
Physiol Plant; 2018 Dec; 164(4):378-384. PubMed ID: 29572864
[TBL] [Abstract][Full Text] [Related]
19. A carrier-free multiplexed gene editing system applicable for suspension cells.
Ju A; Lee SW; Lee YE; Han KC; Kim JC; Shin SC; Park HJ; EunKyeong Kim E; Hong S; Jang M
Biomaterials; 2019 Oct; 217():119298. PubMed ID: 31280073
[TBL] [Abstract][Full Text] [Related]
20. A CRISPR-Cpf1-Assisted Non-Homologous End Joining Genome Editing System of Mycobacterium smegmatis.
Sun B; Yang J; Yang S; Ye RD; Chen D; Jiang Y
Biotechnol J; 2018 Sep; 13(9):e1700588. PubMed ID: 30039929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]